Canada 38-1 Parliament Status: Failed Sponsors 1 N

C-317 — An Act to amend the Food and Drugs Act (mandatory labelling for genetically modified foods)

Last action — Outside order precedence

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. Died on the Order Paper

This bill died with 38-1 Parliament. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Bill Text

  • Bill text (openparliament.ca) View text December 13, 2004

Laws this bill changes

2 sections in 1 law

From the bill's own amending clauses, matched to Justice Canada's consolidation of the Acts and regulations we hold. Open a section to read the law as it stands beside the clause that would change it, and the section as the bill would leave it, marked up by software as a reading aid.

Food and Drugs Act, R.S.C. 1985, c. F-27 2 sections
  • s. 2 Definitions Amends

    Food and Drugs Act, R.S.C. 1985, c. F-27, s. 2

    The bill's clause

    Section 2 of the Food and Drugs Act is amended by adding the following in alphabetical order: 5 1. L’article 2 de la Loi sur les aliments et drogues est modifié par adjonction, selon l’ordre alphabétique, de ce qui suit : 5 “genetically modified” « modifié génétique-ment » “genetically modified”, with respect to a food or one of its components, means that the genetic make-up of the food or component has been modified by a technique that combines DNA fragments of the food or component with DNA fragments from another source in a way that could not occur without the use of modern technology; 10 « modifié génétiquement » Se dit d’un aliment ou d’un de ses composants dont le patrimoine génétique a été modifié au moyen d’une technique utilisant la recombinaison de fragments d’ADN afin de lier entre eux des fragments d’origines différentes d’une manière qui ne pourrait se produire sans l’utilisation de la technologie moderne. 10 15 « modifié génétiquement »“genetically modified” 2. The Act is amended by adding the following after section 7: 15 2. La même loi est modifiée par adjonction, après l’article 7, de ce qui suit : Genetically Modified Food Aliment modifié génétiquement Duty of Minister 7.1 (1) The Minister is responsible for establishing, on the basis of scientific evidence, that a food or one or more of its components are genetically modified. 20 7.1 (1) Le ministre est chargé d’établir, sur le fondement de preuves scientifiques, qu’un aliment ou que l’un ou plusieurs de ses composants sont modifiés génétiquement. 20 Obligation du ministre Publication in the Canada Gazette (2) As soon as the Minister declares that a food or one or more of its components are genetically modified, the Minister shall cause the name of the food to be published in the Canada Gazette. 25 (2…

    The law today

    In this Act, advanced therapeutic product means a therapeutic product that is described in Schedule G or that belongs to a class of therapeutic products that is described in that Schedule; (produit thérapeutique innovant) advertisement includes any representation by any means whatever for the purpose of promoting directly or indirectly the sale or disposal of any food, drug, cosmetic or device; (publicité ou annonce) analyst means an individual designated as an analyst for the purposes of this Act under section 28 or under section 13 of the Canadian Food Inspection Agency Act; (analyste) clinical trial means a study, involving human subjects, for the purpose of discovering or verifying the effects of a drug, a device or a food for a special dietary purpose; (essai clinique) confidential business information, in respect of a person to whose business or affairs the information relates, means — subject to the regulations — business information (a) that is not publicly available, (b) in respect of which the person has taken measures that are reasonable in the circumstances to ensure that it remains not publicly available, and (c) that has actual or potential economic value to the person or their competitors because it is not publicly available and its disclosure would result in a material financial loss to the person or a material financial gain to their competitors; (renseignements commerciaux confidentiels) contraceptive device means any instrument, apparatus, contrivance or substance other than a drug, that is manufactured, sold or represented for use in the prevention of conception; (moyen anticonceptionnel) cosmetic includes any substance or mixture of substances manufactured, sold or represented for use in cleansing, improving or altering the complexion, skin, hair or teeth, and includes deodorants and perfumes; (cosmétique) Department means the Department of Health; (ministère) device means an instrument, apparatus, contrivance or other similar article, or an in vitro reagent, including a component, part or accessory of any of them, that is manufactured, sold or represented for use in (a) diagnosing, treating, mitigating or preventing a disease, disorder or abnormal physical state, or any of their symptoms, in human beings or animals, (b) restoring, modifying or correcting the body structure of human beings or animals or the functioning of any part of the bodies of human beings or animals, (c) diagnosing pregnancy in human beings or animals, (d) caring for human beings or animals during pregnancy or at or after the birth of the offspring, including caring for the offspring, or (e) preventing conception in human beings or animals;however, it does not include such an instrument, apparatus, contrivance or article, or a component, part or accessory of any of them, that does any of the actions referred to in paragraphs (a) to (e) solely by pharmacological, immunological or metabolic means or solely by chemical means in or on the body of a human being or animal; (instrument) drug includes any substance or mixture of substances manufactured, sold or represented for use in (a) the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state, or its symptoms, in human beings or animals, (b) restoring, correcting or modifying organic functions in human beings or animals, or (c) disinfection in premises in which food is manufactured, prepared or kept; (drogue) food includes any article manufactured, sold or represented for use as food or drink for human beings, chewing gum, and any ingredient that may be mixed with food for any purpose whatever; (aliment) food for a special dietary purpose means a food that has been specially processed or formulated (a) to meet the particular requirements of an individual in whom a physical or physiological condition exists as a result of a disease, disorder or abnormal physical state, or (b) to be the sole or primary source of nutrition for an individual; (alime...
    Show s. 2 as this bill would leave it · marked up, a reading aid

    Reading the change…

    Read s. 2 of the Food and Drugs Act →

  • s. 30 Regulations Amends

    Food and Drugs Act, R.S.C. 1985, c. F-27, s. 30 — at 30(1)

    The bill's clause

    Subsection 30(1) of the Act is amended by adding the following after paragraph (e): (e.1) respecting the form of the label referred to in section 7.2 and the sign referred to in section 7.3; 5 3. Le paragraphe 30(1) de la même loi est modifié par adjonction, après l’alinéa e), de ce qui suit : e.1) prévoir la forme de l’étiquette visée à l’article 7.2 et de l’affiche visée à l’article 7.3;

    The law today

    (1) The Governor in Council may make regulations for carrying the purposes and provisions of this Act into effect, and, in particular, but without restricting the generality of the foregoing, may make regulations (a) declaring that any food or drug or class of food or drugs is adulterated if any prescribed substance or class of substances is present therein or has been added thereto or extracted or omitted therefrom; (a.01) declaring that any drug is adulterated if the Minister believes that a prescribed substance contained in that drug presents a serious risk to the environment; (a.1) respecting consultations in respect of orders referred to in section 2.4; (b) respecting (i) the labelling and packaging and the offering, exposing and advertising for sale of food, drugs, cosmetics and devices, (ii) the size, dimensions, fill and other specifications of packages of food, drugs, cosmetics and devices, (iii) the sale or the conditions of sale of any food, drug, cosmetic or device, and (iv) the use of any substance as an ingredient in any food, drug, cosmetic or device,to prevent the purchaser or consumer thereof from being deceived or misled in respect of the design, construction, performance, intended use, quantity, character, value, composition, merit or safety thereof, or to prevent injury to the health of the purchaser or consumer; (b.01) respecting, for the purposes of managing risks to the environment, any of the following: (i) the labelling and packaging and the offering, exposing and advertising for sale of food, drugs, cosmetics and devices, (ii) the size, dimensions, fill and other specifications of packages of food, drugs, cosmetics and devices, (iii) the sale or the conditions of sale of any food, drug, cosmetic or device, and (iv) the use of any substance as an ingredient in any food, drug, cosmetic or device; (b.1) respecting the conduct of clinical trials; (b.2) respecting the issuance of authorizations referred to in section 3.1 and the amendment, suspension and revocation of those authorizations; (b.3) authorizing the Minister to impose terms and conditions on authorizations referred to in section 3.1, including existing authorizations, and to amend those terms and conditions; (b.4) requiring the Minister to ensure that decisions with regard to the issuance, amendment, suspension and revocation of authorizations referred to in section 3.1, and to the imposition and amendment of terms and conditions referred to in paragraph (b.3), along with the reasons for those decisions, are publicly available; (b.5) requiring holders of an authorization referred to in section 3.1, or former holders of such an authorization, to provide the Minister, after the clinical trial to which the authorization relates is completed or discontinued or, if the authorization is suspended or revoked, after the suspension or revocation, with safety information that the holders or former holders receive or become aware of about the drug, device or food for a special dietary purpose that is or was the subject of the clinical trial; (c) prescribing standards of composition, strength, potency, purity, quality or other property of any article of food, drug, cosmetic or device; (d) respecting the importation of food, drugs, cosmetics and devices — including any importation that is solely for the purpose of export — in order to ensure compliance with the provisions of this Act and the regulations; (e) respecting the method of manufacture, preparation, preserving, packaging, storing and testing of any food, drug, cosmetic or device in the interest of, or for the prevention of injury to, the health of the purchaser or consumer or to manage risks to the environment; (f) requiring persons that sell food, drugs, cosmetics or devices, or persons that import them solely for the purpose of export, to maintain any records, reports, electronic data or other documents that the Governor in Council considers necessary for the purposes of this Act; (g) respecti...
    Show s. 30 as this bill would leave it · marked up, a reading aid

    Reading the change…

    Read s. 30 of the Food and Drugs Act →

32 other bills also change it · Follow it →

Sponsors

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors C-317?
C-317 is sponsored by Judy Wasylycia-Leis (NDP).
What is the current status of C-317?
This bill died with 38-1 Parliament. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track C-317?
Track C-317 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on C-317

Find your MP and tell them where you stand on it — or book a meeting about bringing your supporters' voices to the people who decide it.

Stay ahead of C-317

Last checked for changes 4 days ago · updated continuously

One Click Politics tracks every bill in the Parliament of Canada, and in the provinces and territories.

Track this bill →